Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
2014 Comparative Effectiveness Research and the Environment for Health Care Decision-Making

2014 Comparative Effectiveness Research and the Environment for Health Care Decision-Making

Ratings: (0)|Views: 13|Likes:
The fourth annual survey of CER stakeholders reveals continued optimism for the use of comparative effectiveness research (CER) as a tool for improving health care decision-making, but shows the impact of CER has not yet been realized. The survey, conducted by the National Pharmaceutical Council (NPC), also indicates that the Patient-Centered Outcomes Research Institute (PCORI), the agency charged with overseeing this research, has firmly established its key role in the CER effort.
The fourth annual survey of CER stakeholders reveals continued optimism for the use of comparative effectiveness research (CER) as a tool for improving health care decision-making, but shows the impact of CER has not yet been realized. The survey, conducted by the National Pharmaceutical Council (NPC), also indicates that the Patient-Centered Outcomes Research Institute (PCORI), the agency charged with overseeing this research, has firmly established its key role in the CER effort.

More info:

Categories:Types, Brochures
Published by: National Pharmaceutical Council on May 20, 2014
Copyright:Traditional Copyright: All rights reserved

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

09/15/2014

pdf

text

original

 
 AND THE
 
Environment
 
FOR
 
Health Care Decision-Making
Comparative Effectiveness Research
 
Authors/Editors: Andrea Hofelich
 and
Kimberly Westrich
 (National Pharmaceutical Council),
Kevin Walker
 (Penn Quarter Partners), and
Claudia Schur
 and
Annelise Adams
 (Social & Scientific Systems, Inc.)
 
1
Introduction
Now in its fourth year, the National Pharmaceutical Council’s annual survey of health care stakeholders is continuing to shed light on the current environment for comparative effectiveness research (CER) and health care decision-making.
CER has the potential to better inform patients, their care providers, payers and other stakeholders as they make critical decisions about treatments, coverage options and other health care challenges. As our survey results showed this year, that potential is still on the horizon. The stakeholders we surveyed—insurers/health plans, government, employers, researchers/thought leaders, business coalitions and associations who were all knowledgeable about CER—indicated some shifts this year in their attitudes toward the CER landscape. In particular, there were some changes in which organizations were perceived as influential in areas such as funding, monitoring and conducting CER, as well as in other aspects of the health care decision-making environment. We also noted some consistencies in perceptions from previous years. First, stakeholders are continuing to view the Patient-Centered Outcomes Research Institute as a leader in the CER effort. Second, the Agency for Healthcare Research and Quality and the National Institutes of Health remain key players in this space. Perhaps most important, many health care stakeholders are not seeing an immediate impact from CER, although they do expect CER to have a larger impact on decision-making during the next five years.

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->